Enliven Therapeutics
ELVN
ELVN
31 hedge funds and large institutions have $86.3M invested in Enliven Therapeutics in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.16M | |
| 2 | +$1.53M | |
| 3 | +$843K | |
| 4 |
Renaissance Technologies
New York
|
+$314K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$296K |
Top Sellers
| 1 | -$2.99M | |
| 2 | -$704K | |
| 3 | -$671K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$657K |
| 5 |
Two Sigma Investments
New York
|
-$430K |